Anandamide attenuates Th-17 cell-mediated delayed-type hypersensitivity response by triggering IL-10 production and consequent microRNA induction

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Jackson, Austin R ^a   Nagarkatti, Prakash ^a   Nagarkatti, Mitzi ^a  

^a UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; MICRORNA; MICRORNA 125A 5P; MICRORNA 132; MICRORNA 151; MICRORNA 301A; MICRORNA 30E; MICRORNA 374; MICRORNA 491; RETINOID RELATED ORPHAN RECEPTOR GAMMA; UNCLASSIFIED DRUG; AMIDE; ARACHIDONIC ACID DERIVATIVE; CYTOKINE; ENDOCANNABINOID;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL INFILTRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DOWN REGULATION; FEMALE; LIMB SWELLING; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN INDUCTION; TH17 CELL; UPREGULATION; ANIMAL; C57BL MOUSE; DRUG EFFECTS; GENETICS; HYPERSENSITIVITY, DELAYED; IMMUNOLOGY; INFLAMMATION; METABOLISM;

ANIMALS; ARACHIDONIC ACIDS; CYTOKINES; ENDOCANNABINOIDS; HYPERSENSITIVITY, DELAYED; INFLAMMATION; INTERLEUKIN-10; MICE; MICE, INBRED C57BL; MICRORNAS; POLYUNSATURATED ALKAMIDES; TH17 CELLS;

EID: 84899458904     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093954     Document Type: Article

References (57)

1. Hegde VL, Nagarkatti PS, Nagarkatti M (2011) Role of Myeloid-derived Suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PLoS One 6(4): e18281.
2. McKallip RJ, Nagarkatti M, Nagarkatti PS (2005) Δ-9- Tetrahydrocannabinol Enhances Breast Cancer Growth and Metastasis by Suppression of the Antitumor Immune Response. J. Immunol 174:3281-3289. (Pubitemid 40354031)
3. Greineisen WE, Turner H (2010) Immunoactive effects of cannabinoids: Considerations for the therapeutic use of cannabinoid receptor agonists and antagonists. Int Immunopharmacol 10(5):547-55.
4. Pandey R, Hegde VL, Nagarkatti M, Nagarkatti PS (2011) Targeting cannabinoid receptors as a novel approach in the treatment of graft-versus-host disease: evidence from an experimental murine model. J Pharmacol Exp Ther 338(3): 819-828.
5. Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M (2009) Cannabinoids as novel anti-inflammatory drugs. Future Med Chem 1(7):1333-49.
6. De Petrocellis L, Cascio MG, Di Marzo V (2004) The Endocannabinoid System: A general view and latest additions. Br J Pharmacol 141(5): 765-74. (Pubitemid 38446177)
7. Mallat A, Teixeira-Clerc F, Lotersztajn S (2013) Cannabinoid Signaling and liver therapeutics. J. Hepatol 59(4): 891-6
8. Marquez L, Suarez J, Iglesias M, Bermudez-Silva FJ, Rodriguez F, et al. (2009) Ulcerative Colitis induces changes on the expression of the endocannabinoid system in human colonic tissue. PLoS One 4(9): e6893.
9. Horvath B, Mukhopadhyay P, Hasko G, Pacher P (2012) The endocannabinoid system and plant-derived cannabinoids in diabetes and diabetic complications. Am J Pathol 180(2): 432-42.
10. Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, et al. (2007) Attenuation of allergic contact dermatitis through the endocannabinoid system. Science 316(5830): 1494-7. (Pubitemid 46906619)
11. Nakae S, Komiyama Y, Nambu A, Sudo K, Iwase M, et al. (2002) Antigen-specific T cell sensitization is impaired in IL-17-deficient mice, causing suppression of allergic cellular and humoral responses. Immunity 17(3): 375-87. (Pubitemid 35279557)
12. Egan PJ, van Niewenhuijze A, Campbell IK, Wicks IP (2008) Promotion of the local differentiation of murine Th17 cells by synovial macrophages during acute inflammatory arthritis. Arthritis Rheum 58(12): 3720-9.
13. Sakai M, Yamashita K, Takemoto N, Ohshima Y, Tsukimoto M, et al. (2009) Diesel exhaust [DE] aggravates pathology of delayed-type hypersensitivity [DTH] induced by methyl-bovine serum albumin [mBSA] in mice. J Toxicol Sci 34(5): 483-92.
14. Sarnstrand B, Jansson AH, Matuseviciene G, Scheyius A, Pierrou S, et al. (1999) N, N′-diacetyl-L-cystine-the disulfide dimer of N-acetylcysteine- is a potent modulator of contact sensitivity/delayed type hypersensitivity reactions in rodents. J Pharmacol Exp Ther 288(3):1174-84. (Pubitemid 29254156)
15. Nakae S, Nambu A, Sudo K, Iwakura Y (2003) Suppression of immune induction of collagen-induced arthritis in IL-17 deficient mice. J Immunol 171(11): 6173-7. (Pubitemid 37467240)
16. Langrish CL, Chen Y, Blumenschein, Mattson J, Basham B, et al. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med 201: 233-40. (Pubitemid 40189432)
17. Batten M, Li J, Yi S, Kljavin NM, Danilenko DM, et al. (2006) Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells. Nat Immunol 7(9): 929-36. (Pubitemid 44263906)
18. Tajiri K, Shimojo N, Sakai S, Machino-Ohtsuka T, Imanaka-Yoshida K, et al. (2013) Pitavastatin Regulates Helper T-Cell Differentiation and Ameliorates Autoimmune Myocarditis in Mice. Cardiovasc Drugs Ther 27(5): 413-24.
19. Mach C, Kim J, Soibam B, Creighton CJ, Hawkins SM, et al. (2013) Novel MicroRNAs Regulating Proliferation and Apoptosis in Uterine Papillary Serous Carcinomas. Cancer Lett 335(2): 314-22.
20. Cai B, An Y, Lv N, Chen J, Tu M, et al. (2013) miRNA-181b increases the sensitivity of pancreatic ductal adenocarcinoma cells to gemcitabine in vitro and in nude mice by targeting BCL-2. Oncol Rep 29(5): 1769-76
21. Wang L, Jia XJ, Jiang HJ, Du Y, Yang F, et al. (2013) MiRNA-185, MiRNA-96 and MiRNA-223 Repress Selective HDL-Cholesterol Uptake through Posttranscriptional Inhibition of Scavenger Receptor Class BI in Hepatic Cells. Mol Cell Biol 33(10): 1956-64.
22. Cao L, Kong LP, Yu ZB, Han SP, Bai YF, et al. (2012) microRNA expression profiling of the developing mouse heart. Int J Mol Med 30(5): 1095-104.
23. Lewis BP, Burge CB, Bartel DP (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120: 15-20. (Pubitemid 40094598)
24. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegens heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75:843-854. (Pubitemid 24014542)
25. Guan H, Fan D, Mrelashvili D, Hao H, Singh NP, et al. (2012) MicroRNA let- 7e is associated with the pathogenesis of experimental autoimmune encephalomyelitis. Eu. J. Immunol 43(1): 104-114.
26. Yao R, Ma YL, Liang W, Li HH, Ma ZJ, et al. (2012) MicroRNA-155 modulates Treg and Th17 cell differentiation and Th17 cell function by targeting SOCS1. PLoS One 7(10):e46082.
27. Takahashi H, Kanno T, Nakayamada S, Hirahara K, Sciume G, et al. (2012) TGF-β and retinoic acid induce the microRNA miR-10a, which targets Bcl-6 and contrains the plasticity of helper T. cells.
28. Solberg OD, Ostrin EJ, Love MI, Peng JC, Bhakta NR et al. (2012) Airway Epithelial miRNA Expression is Altered in Asthma. Am. J. Respir. Crit. Care Med 186(10): 965-974.
29. Lu TX, Hartner J, Lim EJ, Fabry V, Mingler MK, et al. (2011) MicroRNA-21 limits in vivo immune response-mediated activation of the IL-12/IFN-γ Pathway, Th1 Polarization, and the Severity of Delayed-Type Hypersensitivity. J. Immunol 187(6): 3362-3373.
30. Do Y, McKallip RJ, Nagarkatti M, Nagarkatti PS (2004) Activation through Cannabinoid Receptors 1 and 2 on Dendritic Cells Triggers NF-κB-Dependent Apoptosis: Novel Role for Endogenous and Exogenous Cannabinoids in Immunoregulation. J. Immunol 173(4): 2373-2382. (Pubitemid 39063093)
31. 9-Tetrahydrocannabinol-Induced Apoptosis in the Thymus and Spleen as a Mechanism of Immunosuppression in Vitro and in Vivo. J Pharmacol Exp Ther 302(2): 451-465.
32. Newton CA, Lu T, Nazian SJ, Perkins I, Friedman H, et al. (2004) The THCinduced suppression of Th1 polarization in response to Legionella pneumophila infection is not mediated by increases in corticosterone and PGE2. J Leukoc Biol 76(4): 854-61. (Pubitemid 39313722)
33. Hegde VL, Nagarkatti PS, Nagarkatti M (2011) Role of Myeloid-derived Suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabindiol. PLoS One 6(4): e18281.
34. Hegde VL, NagarkattiM, Nagarkatti PS (2010) Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties. Eur. J. Immunol 40: 3358-3371.
35. Hegde VL, Hegde S, Cravatt BF, Hofseth LJ, Nagarkatti M, et al. (2008) Attenuation of experimental autoimmune hepatitis by exogenous and endogenous cannabinoids: involvement of regulatory T cells. Mol Pharmacol 74(1): 20-33. (Pubitemid 351872155)
36. Pandey R, Mousawy K, Nagarkatti M, Nagarkatti P (2009) Endocannabinoids and immune regulation. Pharmacol Res 60(2): 85-92.
37. Costola-de-Souza C, Ribeiro A, Ferraz-de-Paula V, Calefi AS, Aloia TP, et al. (2013) Monoacylglycerol Lipase inhibition attenuates acutes Lung Injury in Mice. PLoS One 8(10):e77706.
38. Schwartz H, Blanco FJ, Lotz M (1994) Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol 55: 107-115. (Pubitemid 24356812)
39. Berdyshev EV, Biochot E, Germain N, Allain N, Anger JP, et al. (1997) Influence of fatty acid ethanolamides and Δ9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eu. J. Pharmacol 330: 231-40. (Pubitemid 27296727)
40. Maccarrone M, De Petrocellis L, Bari M, Fezza F, Salvati S, et al. (2001) Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases Anandamide levels in human peripheral lymphocytes. Arch Biochem Biophys 393: 321-28. (Pubitemid 32907190)
41. Sugamura K, Sugiyama S, Nozaki T, Matsuzawa Y, Izumiya Y, et al. (2009) Activated Endocannabinoid System in Coronary Artery Disease and Antiinflammatory Effects of Cannabinoid 1 Receptor Blockade on Macrophages. Circulation 119:28-36.
42. Matias I, Pochard P, Orlando P, Salzet M, Pestel J, et al. (2002) Presence and regulation of the endocannabinoid system in human dendritic cells. Eur J Biochem 269:3771-8. (Pubitemid 34989126)
43. Fiorentino DF, Bond MW, Mosmann TR (1989) Th2 Clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med 170(6):2081-95.
44. Liu DZ, Hu CM, Huang CH, Wey SP, Jan TR (2010) Cannabidiol attenuates delayed-type hypersensitivity via suppressing T-cell and macrophage reactivity. Acta Pharmacol Sin 31(12):1611-7.
45. Kozela E, Juknat A, Kaushansky N, Rimmerman N, Ben-Nun A, et al. (2013) Cannabinoids decease the Th17 inflammatory autoimmune phenotype. J. Neuroimmune Pharmacol Epub.
46. Chaudhry A, Samstein RM, Treuting P, Liang Y, Pils MC, et al. (2011) Interleukin-10 signaling in Regulatory T Cells is Required for Suppression of Th17 Cell-Mediated Inflammation. Immunity 34:566-78.
47. Kosaka S, Tamauchi H, Terashima M, Maruyama H, Habu S, et al. (2011) IL-10 controls Th2-type cytokine production and eosinophil infiltration in a mouse model of allergic airway inflammation. Immunobiology 216(7): 811-20.
48. Callard RE (2007) Decision-making by the immune response. Immunol Cell Biol 85(4):300-5
49. Correa F, Hernangomez-Herrero M, Mestre L, Loria F, Docagne F, et al. (2011) The endocannabinoid Anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for cross-talk between IL12p70/IL23 axis and IL-10 in microglial cells. Brain Behav Immun 25(4):736-49.
50. Wu Z, Lu H, Sheng J, Li L (2012) Inductive microRNA-21 impairs antimycobacterial responses by targeting IL-12 and Bcl-2. FEBS Lett 586(16): 2459-67.
51. Nambu A, Nakae S, Iwakura Y (2006) IL-1b, but not IL-1 a, is required for antigen specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity response. Int Immunol 18(5): 701-12. (Pubitemid 43779060)
52. Lalor SJ, Dungan LS, Sutton CE, Basdeo SA, Fletcher JM, et al. (2011) Caspase-1-processed cytokines IL-1beta and IL-18 promote IL-17 production by gammadelta and CD4 T cells that mediate autoimmunity. J Immunol 186(10):5738-48.
53. Lee WW, Kang SW, Choi J, Lee SH, Shah K, et al. (2009) Regulating human Th17 cells via differential expression of IL-1 receptor. Blood 115(3): 530-40.
54. Szabo SJ, Kim ST, Costa GL, Zhang X, Fathman CG, et al. (2000) A Novel transcription factor, T-bet, directs Th1 Lineage commitment. Cell 100(6):655-69.
55. Kozela E, Lev N, Kaushanksy N, Eilam R, Rimmerman N, et al. (2011) Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice. Br J Pharmacol 163(7): 1507-19.
56. Echigo R, Sugimoto N, Yachie A, Ohno-Shosaku T (2012) Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-kB and cell growth in U87MG human malignant glioma cells. Oncol Rep 28(4): 1176-80.
57. Mimeault M, Pommery N, Wattez N, Bailly C, Henichart JP (2003) Antiproliferative and apoptotic effects of Anandamide in human prostate cancer cell lines: implications of epidermal growth factor receptor down-regulation and ceramide production. Prostate 56(1): 1-12. (Pubitemid 36613150)